Literature DB >> 20132338

Microembolic air load during contrast-transcranial Doppler: a trigger for migraine with aura?

Luigi Caputi1, Susanna Usai, Maria R Carriero, Licia Grazzi, Domenico D'Amico, Chiara Falcone, Gian P Anzola, Massimo Del Sette, Eugenio Parati, Gennaro Bussone.   

Abstract

BACKGROUND: There is a well-known association between migraine with aura (MA) and right-to-left shunt (RILES) because of patent foramen ovale (PFO). The occurrence of MA attacks after microbubble (MB) injection during contrast-enhanced transcranial Doppler (ce-TCD) has been recently described.
OBJECTIVES: The aim of this study was to analyze the prevalence of RILES in a consecutive cohort of MA patients and to characterize the occurrence of MA attacks after diagnostic ce-TCD.
METHODS: A total of 159 consecutive MA patients underwent ce-TCD with air-mixed saline to disclose RILES. RILES was characterized in terms of MB amount (small-moderate or large) and occurrence at rest and/or during Valsalva maneuver (permanent or latent).
RESULTS: RILES was revealed in 79/159 patients (∼ 50%). Permanent RILES were detected in 56/79 (71%) and latent RILES in 23/79 (29%) MA patients. The occurrence of a typical MA attack was overall observed in 12/159 patients (7.5%; 95% CI: 4-12.8%), but arose only in RILES-positive ones, immediately after ce-TCD (12/79; 15.2%; P< .001). All 12 patients had permanent RILES (12/56; 21.4%; P= .015) and MA attack was mostly observed in large RILES-positive patients, even without statistical significance (P= .118).
CONCLUSIONS: Microembolic air load could act as a trigger of MA attack. According to recent studies and to the clinical characteristics observed in our patients, microembolization because of MB injection might provoke a decrease in cerebral oxygen saturation, thus triggering cortical spreading depression and, thereafter, MA attack. Larger and prospective studies will be necessary to confirm our data and observe a wider correlation.

Entities:  

Mesh:

Year:  2010        PMID: 20132338     DOI: 10.1111/j.1526-4610.2010.01621.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  7 in total

Review 1.  Patent foramen ovale: anatomy, outcomes, and closure.

Authors:  Patrick A Calvert; Bushra S Rana; Anna C Kydd; Leonard M Shapiro
Journal:  Nat Rev Cardiol       Date:  2011-02-01       Impact factor: 32.419

Review 2.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

Review 3.  Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

Authors:  Charles Stevens Leger; Joseph F X DeSouza
Journal:  Front Neurol       Date:  2017-03-20       Impact factor: 4.003

4.  Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.

Authors:  Sara Mazzucco; Linxin Li; Lucy Binney; Peter M Rothwell
Journal:  Lancet Neurol       Date:  2018-06-07       Impact factor: 59.935

Review 5.  The Patent Foramen Ovale and Migraine: Associated Mechanisms and Perspectives from MRI Evidence.

Authors:  Wenfei Cao; Yinbo Shen; Jiaqi Zhong; Zhenhong Chen; Nizhuan Wang; Jiajun Yang
Journal:  Brain Sci       Date:  2022-07-18

6.  Paradoxical air microembolism induces cerebral bioelectrical abnormalities and occasionally headache in patent foramen ovale patients with migraine.

Authors:  Eser Başak Sevgi; Sefik Evren Erdener; Mehmet Demirci; Mehmet Akif Topcuoglu; Turgay Dalkara
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

7.  Intravascular Endothelin-1 does not trigger or increase susceptibility to Spreading Depolarizations.

Authors:  Kazutaka Sugimoto; Andreia Morais; Homa Sadeghian; Tao Qin; David Y Chung; Messoud Ashina; Anders Hougaard; Cenk Ayata
Journal:  J Headache Pain       Date:  2020-10-27       Impact factor: 7.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.